The death effector domain protein PEA-15 negatively regulates T-cell receptor signaling

FASEB Journal

Volumn 24, Issue 8, 2010, Pages 2818-2828

  Pastorino, Sandra ^a   Renganathan, Hemamalini ^a   Caliva, Maisel J ^a   Filbert, Erin L ^b   Opoku Ansah, John ^a   Sulzmaier, Florian J ^a   Gawecka, Joanna E ^a   Werlen, Guy ^c   Shaw, Andrey S ^b,d   Ramos, Joe W ^a  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ERK MAP kinase; IL 2; Jurkat T cells; Proliferation

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; DEATH RECEPTOR; INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE; PEA 15 PROTEIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; C57BL 6 MOUSE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENETIC CODE; HOMEOSTASIS; IMMUNE RESPONSE; IN VIVO STUDY; LEUKEMIA CELL LINE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; SPLEEN CELL; T LYMPHOCYTE; THYMUS; WILD TYPE;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL PROLIFERATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INTERLEUKIN-2; JURKAT CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHOPROTEINS; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

MUS;

EID: 77955807430     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.09-144295     Document Type: Article

References (42)

1. Formstecher, E., Ramos, J. W., Fauquet, M., Calderwood, D. A., Hsieh, J. C., Canton, B., Nguyen, X. T., Barnier, J. V., Camonis, J., Ginsberg, M. H., and Chneiweiss, H. (2001) PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. Dev. Cell 1, 239-250
2. Renganathan, H., Vaidyanathan, H., Knapinska, A., and Ramos, J. W. (2005) Phosphorylation of PEA-15 switches its binding specificity from ERK/MAPK to FADD. Biochem. J. 390, 729-735
3. Valmiki, M. G., and Ramos, J. W. (2009) Death effector domain-containing proteins. Cell. Mol. Life Sci. 66, 814-830
4. Whitehurst, A. W., Robinson, F. L., Moore, M. S., and Cobb, M. H. (2004) The death effector domain protein PEA-15 prevents nuclear entry of ERK2 by inhibiting required interactions. J. Biol. Chem. 279, 12840-12847
5. Palacios, E. H., and Weiss, A. (2004) Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation. Oncogene 23, 7990-8000
6. Mustelin, T., and Tasken, K. (2003) Positive and negative regulation of T-cell activation through kinases and phosphatases. Biochem. J. 371, 15-27
7. Horejsi, V., Zhang, W., and Schraven, B. (2004) Transmembrane adaptor proteins: organizers of immunoreceptor signalling. Nat. Rev. Immunol. 4, 603-616
8. Wu, J. N., and Koretzky, G. A. (2004) The SLP-76 family of adapter proteins. Semin. Immunol. 16, 379-393
9. Marshall, C. J. (1995) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179-185
10. Fischer, A. M., Katayama, C. D., Pages, G., Pouyssegur, J., and Hedrick, S. M. (2005) The role of erk1 and erk2 in multiple stages of T cell development. Immunity 23, 431-443
11. Dong, C., Davis, R. J., and Flavell, R. A. (2002) MAP kinases in the immune response. Annu. Rev. Immunol. 20, 55-72
12. Werlen, G., Hausmann, B., Naeher, D., and Palmer, E. (2003) Signaling life and death in the thymus: timing is everything. Science 299, 1859-1863
13. Starr, T. K., Jameson, S. C., and Hogquist, K. A. (2003) Positive and negative selection of T cells. Annu. Rev. Immunol. 21, 139-176
14. alberola-Ila, J., and Hernandez-Hoyos, G. (2003) The Ras/ MAPK cascade and the control of positive selection. Immunol. Rev. 191, 79-96
15. McNeil, L. K., Starr, T. K., and Hogquist, K. A. (2005) A requirement for sustained ERK signaling during thymocyte positive selection in vivo. Proc. Natl. Acad. Sci. U. S. A. 102, 13574-13579
16. Whitehurst, C. E., and Geppert, T. D. (1996) MEK1 and the extracellular signal-regulated kinases are required for the stimulation of IL-2 gene transcription in T cells. J. Immunol. 156, 1020-1029
17. Dumont, F. J., Staruch, M. J., Fischer, P., DaSilva, C., and Camacho, R. (1998) Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production. J. Immunol. 160, 2579-2589
18. Stefanova, I., Hemmer, B., Vergelli, M., Martin, R., Biddison, W. E., and Germain, R. N. (2003) TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways. Nat. Immunol. 4, 248-254
19. Murphy, L. O., Smith, S., Chen, R. H., Fingar, D. C., and Blenis, J. (2002) Molecular interpretation of ERK signal duration by immediate early gene products. Nat. Cell Biol. 4, 556-564
20. Daniels, M. A., Teixeiro, E., Gill, J., Hausmann, B., Roubaty, D., Holmberg, K., Werlen, G., Hollander, G. A., Gascoigne, N. R., and Palmer, E. (2006) Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling. Nature 444, 724-729
21. Wang, X., Simeoni, L., Lindquist, J. A., Saez-Rodriguez, J., Ambach, A., Gilles, E. D., Kliche, S., and Schraven, B. (2008) Dynamics of proximal signaling events after TCR/CD8-mediated induction of proliferation or apoptosis in mature CD8+ T cells. J. Immunol. 180, 6703-6712
22. Kitsberg, D., Formstecher, E., Fauquet, M., Kubes, M., Cordier, J., Canton, B., Pan, G., Rolli, M., Glowinski, J., and Chneiweiss, H. (1999) Knock-out of the neural death effector domain protein PEA-15 demonstrates that its expression protects astrocytes from TNFalpha-induced apoptosis. J. Neurosci. 19, 8244-8251
23. Condorelli, G., Vigliotta, G., Cafieri, A., Trencia, A., Andalo, P., Oriente, F., Miele, C., Caruso, M., Formisano, P., and Beguinot, F. (1999) PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis. Oncogene 18, 4409-4415
24. Ricci-Vitiani, L., Pedini, F., Mollinari, C., Condorelli, G., Bonci, D., Bez, A., Colombo, A., Parati, E., Peschle, C., and De, M. R. (2004) Absence of caspase 8 and high expression of PED protect primitive neural cells from cell death. J. Exp. Med. 200, 1257-1266
25. Vaidyanathan, H., Opoku-Ansah, J., Pastorino, S., Renganathan, H., Matter, M. L., and Ramos, J. W. (2007) ERK MAP kinase is targeted to RSK2 by the phosphoprotein PEA-15. Proc. Natl. Acad. Sci. U. S. A. 104, 19837-19842
26. Chou, F. L., Hill, J. M., Hsieh, J. C., Pouyssegur, J., Brunet, A., Glading, A., Uberall, F., Ramos, J. W., Werner, M. H., and Ginsberg, M. H. (2003) PEA-15 binding to ERK1/2 MAPKs is required for its modulation of integrin activation. J. Biol. Chem. 278, 52587-52597
27. Krueger, J., Chou, F. L., Glading, A., Schaefer, E., and Ginsberg, M. H. (2005) Phosphorylation of phosphoprotein enriched in astrocytes (PEA-15) regulates extracellular signal-regulated kinase- dependent transcription and cell proliferation. Mol. Biol. Cell 16, 3552-3561
28. Gervais, M., Dugourd, C., Muller, L., Ardidie, C., Canton, B., Loviconi, L., Corvol, P., Chneiweiss, H., and Monnot, C. (2006) Akt down-regulates ERK1/2 nuclear localization and angiotensin II-induced cell proliferation through PEA-15. Mol. Biol. Cell 17, 3940-3951
29. Pages, G., Guerin, S., Grall, D., Bonino, F., Smith, A., Anjuere, F., Auberger, P., and Pouyssegur, J. (1999) Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science 286, 1374-1377
30. Agrawal, A., Dillon, S., Denning, T. L., and Pulendran, B. (2006) ERK1-/- mice exhibit Th1 cell polarization and increased susceptibility to experimental autoimmune encephalomyelitis. J. Immunol. 176, 5788-5796
31. Schaeffer, H. J., and Weber, M. J. (1999) Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell. Biol. 19, 2435-2444
32. Zhong, X. P., Hainey, E. A., Olenchock, B. A., Jordan, M. S., Maltzman, J. S., Nichols, K. E., Shen, H., and Koretzky, G. A. (2003) Enhanced T cell responses due to diacylglycerol kinase zeta deficiency. Nat. Immunol. 4, 882-890
33. Sun, Z., Arendt, C. W., Ellmeier, W., Schaeffer, E. M., Sunshine, M. J., Gandhi, L., Annes, J., Petrzilka, D., Kupfer, A., Schwartzberg, P. L., and Littman, D. R. (2000) PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes. Nature 404, 402-407
34. Park, J. H., and Levitt, L. (1993) Overexpression of mitogen-activated protein kinase (ERK1) enhances T-cell cytokine gene expression: role of AP1, NF-AT, and NF-KB. Blood 82, 2470-2477
35. Li, Y. Q., Hii, C. S., Der, C. J., and Ferrante, A. (1999) Direct evidence that ERK regulates the production/secretion of interleukin- 2 in PHA/PMA-stimulated T lymphocytes. Immunology 96, 524-528
36. Budd, R. C. (2002) Death receptors couple to both cell proliferation and apoptosis. J. Clin. Invest. 109, 437-441
37. Tibbetts, M. D., Zheng, L., and Lenardo, M. J. (2003) The death effector domain protein family: regulators of cellular homeostasis. Nat. Immunol. 4, 404-409
38. Estelles, A., Charlton, C. A., and Blau, H. M. (1999) The phosphoprotein protein PEA-15 inhibits Fas- but increases TNF-R1-mediated caspase-8 activity and apoptosis. Dev. Biol. 216, 16-28
39. Budd, R. C., Yeh, W. C., and Tschopp, J. (2006) cFLIP regulation of lymphocyte activation and development. Nat. Rev. Immunol. 6, 196-204
40. Barnhart, B. C., Lee, J. C., Alappat, E. C., and Peter, M. E. (2003) The death effector domain protein family. Oncogene 22, 8634-8644
41. Luschen, S., Falk, M., Scherer, G., Ussat, S., Paulsen, M., and dam-Klages, S. (2005) The Fas-associated death domain protein/ caspase-8/c-FLIP signaling pathway is involved in TNF-induced activation of ERK. Exp. Cell. Res. 310, 33-42
42. Ramos, J. W. (2005) Cancer Res. center hotline: PEA-15 phosphoprotein: a potential cancer drug target. Hawaii Med. J. 64, 77-80